Zimbabwe has rejected a significant US healthcare agreement valued at $367m (272 million pounds) spanning five years due to Washington's demand for confidential biological samples.
This rejection was revealed after a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
A government spokesperson later explained that the US was demanding access to genetic material for scientific study and commercial gain while refused to share the benefits from future medical innovations.
"We will now turn to the difficult and regrettable task of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for continued dialogue to find a agreement agreeable to all parties so the nation's vital HIV programme can proceed.
Broader Context
This rejection comes after a comparable case in Kenya, where a court halted a similar health funding agreement following legal challenges were raised about the safety of Kenyans' health data.
Since resuming office recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had overseen assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was seeking direct bilateral deals to boost openness and responsibility.
According to reports, 16 nations in Africa have so far signed these new health pacts, representing over $18.3bn of fresh investment.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this partnership might have yielded significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information indefinitely, with no equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Effectively, our country would provide the basic resources for scientific discovery without any assurance that the final treatments would be accessible to our population if a new health crisis arise."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were undermining structures already established via the global organization.
The spokesperson cited its Pandemic Benefit-Sharing system created to manage future global health emergencies.
"This system is intended to ensure that when a country contributes its samples, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We encourage ongoing discussions with our US partners on how subsequent collaboration might be designed in a manner that honours the independence and interests of both nations."
Health Experts Response
A leading public health body said it understood the government's concerns, but suggested that negotiations must proceed given that a large portion of the country's HIV programmes were funded by international support.
"Where technical issues arise, such as those involving information security or agreement terms, these can frequently be addressed through detailed discussion and negotiated safeguards," it commented.
The halted deal highlights the ongoing challenges between accepting much-needed international aid and protecting local interests in an ever more interconnected world.